3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
15
Recurrence
8
Hodgkin Disease
6
Breast Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
5
Sezary Syndrome
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Mycosis Fungoides
4
Leukemia, Myeloid, Acute
4
Leukemia
4
Waldenstrom Macroglobulinemia
3
Neoplasms
3
Myelodysplastic Syndromes
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Prostatic Neoplasms
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Melanoma
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Follicular
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Immunoblastic Lymphadenopathy
2
Glioma
2
Diffuse Intrinsic Pontine Glioma
2
Carcinoma, Renal Cell
2
Interventions
Sorafenib
23
Bevacizumab
11
Radiosurgery
6
Capecitabine
6
Radiofrequency Ablation
5
Oxaliplatin
5
Fluorouracil
5
Doxorubicin
5
pembrolizumab
4
Sunitinib
4
Erlotinib Hydrochloride
4
Cisplatin
4
Ramucirumab
3
Radiotherapy
3
Nivolumab
3
Leucovorin
3
Carboplatin
3
tremelimumab
2
spartalizumab
2
perflutren
2
derazantinib
2
carotuximab
2
Mitomycin
2
Magnetic Resonance Spectroscopy
2
Magnetic Resonance Imaging
2
Ipilimumab
2
Immunohistochemistry
2
Gemcitabine
2
Folfox protocol
2
Fluorodeoxyglucose F18
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Liver Neoplasms
×
Panobinostat
×
Clear all
No trials found.